Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Translational Development Acquisition (TDAC) Equity Ratio (2023 - 2026)

Translational Development Acquisition's Equity Ratio history spans 4 years, with the latest figure at 0.04 for Q1 2026.

  • On a quarterly basis, Equity Ratio fell 10.55% to 0.04 in Q1 2026 year-over-year; TTM through Mar 2026 was 0.04, a 10.55% decrease, with the full-year FY2025 number at 0.04, down 12.57% from a year prior.
  • Equity Ratio came in at 0.04 for Q1 2026, down from 0.04 in the prior quarter.
  • The five-year high for Equity Ratio was 0.03 in Q4 2024, with the low at 251.19 in Q4 2023.
  • Historically, Equity Ratio has averaged 35.91 across 4 years, with a median of 0.04 in 2025.
  • Biggest five-year swings in Equity Ratio: surged 99.99% in 2024 and later dropped 12.57% in 2025.
  • Year by year, Equity Ratio stood at 251.19 in 2023, then skyrocketed by 99.99% to 0.03 in 2024, then decreased by 12.57% to 0.04 in 2025, then fell by 3.36% to 0.04 in 2026.
  • Business Quant data shows Equity Ratio for TDAC at 0.04 in Q1 2026, 0.04 in Q4 2025, and 0.04 in Q3 2025.